Homeopathic vs conventional treatment of vertigo: A randomized double- blind controlled clinical study

Archives of Otolaryngology - Head and Neck Surgery

Volumn 124, Issue 8, 1998, Pages 879-885

  Weiser, Michael ^a   Strösser, Wolfgang ^b   Klein, Peter ^c  

^a Biologische Heilmittel Heel GmbH   (Germany)

^b Clin Research and Pharma Consulting   (Germany)

^c Datenservice Eva Hönig GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMBERGRIS; BETAHISTINE; HOMEOPATHIC AGENT; PETROLEUM; PLACEBO; UNCLASSIFIED DRUG; VERTIGOHEEL;

ADULT; AGED; ARTICLE; BIOEQUIVALENCE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONIUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GOOD CLINICAL PRACTICE; HEADACHE; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TREMOR; VERTIGO;

EID: 0031850037     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.124.8.879     Document Type: Article

References (22)

1. Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med. 1990;150:1685-1689.
2. Parker SW. Otoneurology. In: Stein JH, ed. Internal Medicine. 4th rev ed. St Louis, Mo: Mosby-Year Book Inc; 1994:chap 115.
3. Claussen CF. Der Schwindel und seine biologische Behandlung mit Vertigoheel: Ergebnisse von klinisch-experimentellen Untersuchungen. Biol Med. 1983;6: 531-532.
4. Claussen CF. Die Behandlung des Syndroms des verlangsamten Hirnstamms mit Vertigoheel. Biol Med. 1985;14:447-470,510-514.
5. Zenner S, Borho B, Metelmann H. Schwindel und seine Beeinflußbarkeit durch ein homöpathisches Kombinationspräparat. Erfahrungsheilkunde. 1991;6:423-429.
6. Claussen CF, Bergmann J, Bertora G, Claussen E. Klinisch-experimentelle Prü fung und äquilibriometrische Messungen zum Nachweis der therapeutischen Wirksamkeit eines homöpathischen Arzneimittels bestehend aus Ambra, Cocculus, Conium, und Petroleum bei der Diagnose Vertigo und Nausea. Arzneimittelforschung. 1984;34:1791-1798.
7. Aantaa E. Treatment of acute vestibular vertigo. Acta Otolaryngol (Stockh). 1991; 479:44-47.
8. Elbaz P. Flunarizine and betahistine: two different therapeutic approaches in vertigo compared in a double-blind study. Acta Octolaryngol (Stockh). 1988;460: 143-148.
9. Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R. Betahistine dihydrochloride versus flunarizine: a double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease. Abstract Acta Otolaryngol (Stockh). 1991;490:2-10.
10. Tran Ba Huy P, Meyrand MF. Le dichlorhydrate de bétahistine en deux prises ou en trois prises par jour. J Fr Oto-Rhino-Laryngol. 1992;41 (suppl 3):I-IV.
11. Canty P, Valentine J, Papworth SJ. Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc® versus placebo. J Laryngol Otol. 1981;95:687-692.
12. Oosterveld WJ. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin: a double-blind placebo controlled study. J Laryngol Otol. 1984;98:37-41.
13. Spilker B. Guide to Clinical Trials. New York, NY: Raven Press; 1990.
14. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, Mass: The Health Institute, New England Medical Center; 1994.
15. Wei LJ, Lachin JM. Two-sample asymptomatically distribution-free tests for incomplete multivariate observations. J Am Stat Assoc. 1984;79:653-661.
16. Lachin JM. Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations. Stat Med. 1992;11:1151-1170.
17. Lachin JM. Distribution-free marginal analysis of repeated measures. Drug Inform J. 1996;30:1017-1028.
18. Biostatistic Methodology in Clinical Trials in Applications for Marketing Authorisation for Medicinal Products. Brussels, Belgium: European Union Committee for Proprietary Medicinal Products; 1994. Guidance note III/3630/92-EN.
19. Mizukoshi K, Watanabe I, Matsunaga T, et al. Clinical evaluation of medical treatment for Ménière's disease, using a double-blind controlled study. Am J Otol. 1988;9:418-422.
20. Portmann G. The old and new in Ménière's disease: over 60 years in retrospect and a look to the future. Otolaryngol Clin North Am. 1980;13:292-312.
21. Elinson J, Siegmann AE. Sociomedical Health Indicators. Farmingdale, NY: Baywood Publishing Co Inc; 1979.
22. Spilker B. Quality-of-Life Assessment in Clinical Trials. New York, NY: Raven Press; 1990.